Literature DB >> 23307809

Recognition of microbial and mammalian phospholipid antigens by NKT cells with diverse TCRs.

Raju V V Tatituri1, Gerald F M Watts, Veemal Bhowruth, Nathaniel Barton, Alissa Rothchild, Fong-Fu Hsu, Catarina F Almeida, Liam R Cox, Lothar Eggeling, Susanna Cardell, Jamie Rossjohn, Dale I Godfrey, Samuel M Behar, Gurdyal S Besra, Michael B Brenner, Manfred Brigl.   

Abstract

CD1d-restricted natural killer T (NKT) cells include two major subgroups. The most widely studied are Vα14Jα18(+) invariant NKT (iNKT) cells that recognize the prototypical α-galactosylceramide antigen, whereas the other major group uses diverse T-cell receptor (TCR) α-and β-chains, does not recognize α-galactosylceramide, and is referred to as diverse NKT (dNKT) cells. dNKT cells play important roles during infection and autoimmunity, but the antigens they recognize remain poorly understood. Here, we identified phosphatidylglycerol (PG), diphosphatidylglycerol (DPG, or cardiolipin), and phosphatidylinositol from Mycobacterium tuberculosis or Corynebacterium glutamicum as microbial antigens that stimulated various dNKT, but not iNKT, hybridomas. dNKT hybridomas showed distinct reactivities for diverse antigens. Stimulation of dNKT hybridomas by microbial PG was independent of Toll-like receptor-mediated signaling by antigen-presenting cells and required lipid uptake and/or processing. Furthermore, microbial PG bound to CD1d molecules and plate-bound PG/CD1d complexes stimulated dNKT hybridomas, indicating direct recognition by the dNKT cell TCR. Interestingly, despite structural differences in acyl chain composition between microbial and mammalian PG and DPG, lipids from both sources stimulated dNKT hybridomas, suggesting that presentation of microbial lipids and enhanced availability of stimulatory self-lipids may both contribute to dNKT cell activation during infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23307809      PMCID: PMC3562825          DOI: 10.1073/pnas.1220601110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

Review 1.  The biology of NKT cells.

Authors:  Albert Bendelac; Paul B Savage; Luc Teyton
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

2.  Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets.

Authors:  Julia Rolf; Emma Berntman; Martin Stenström; Emma M K Smith; Robert Månsson; Hanna Stenstad; Tetsuya Yamagata; William Agace; Mikael Sigvardsson; Susanna L Cardell
Journal:  Mol Immunol       Date:  2008-03-04       Impact factor: 4.407

Review 3.  The fidelity, occasional promiscuity, and versatility of T cell receptor recognition.

Authors:  Dale I Godfrey; Jamie Rossjohn; James McCluskey
Journal:  Immunity       Date:  2008-03       Impact factor: 31.745

Review 4.  The unique role of natural killer T cells in the response to microorganisms.

Authors:  Emmanuel Tupin; Yuki Kinjo; Mitchell Kronenberg
Journal:  Nat Rev Microbiol       Date:  2007-05-08       Impact factor: 60.633

5.  Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.

Authors:  Jochen Mattner; Kristin L Debord; Nahed Ismail; Randal D Goff; Carlos Cantu; Dapeng Zhou; Pierre Saint-Mezard; Vivien Wang; Ying Gao; Ning Yin; Kasper Hoebe; Olaf Schneewind; David Walker; Bruce Beutler; Luc Teyton; Paul B Savage; Albert Bendelac
Journal:  Nature       Date:  2005-03-24       Impact factor: 49.962

6.  Recognition of bacterial glycosphingolipids by natural killer T cells.

Authors:  Yuki Kinjo; Douglass Wu; Gisen Kim; Guo-Wen Xing; Michael A Poles; David D Ho; Moriya Tsuji; Kazuyoshi Kawahara; Chi-Huey Wong; Mitchell Kronenberg
Journal:  Nature       Date:  2005-03-24       Impact factor: 49.962

7.  Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria.

Authors:  Yuki Kinjo; Emmanuel Tupin; Douglass Wu; Masakazu Fujio; Raquel Garcia-Navarro; Mohammed Rafii-El-Idrissi Benhnia; Dirk M Zajonc; Gil Ben-Menachem; Gary D Ainge; Gavin F Painter; Archana Khurana; Kasper Hoebe; Samuel M Behar; Bruce Beutler; Ian A Wilson; Moriya Tsuji; Timothy J Sellati; Chi-Huey Wong; Mitchell Kronenberg
Journal:  Nat Immunol       Date:  2006-08-20       Impact factor: 25.606

8.  Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide.

Authors:  Alex Jahng; Igor Maricic; Carlos Aguilera; Susanna Cardell; Ramesh C Halder; Vipin Kumar
Journal:  J Exp Med       Date:  2004-03-29       Impact factor: 14.307

9.  Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria.

Authors:  Isabel Sada-Ovalle; Asako Chiba; Adaena Gonzales; Michael B Brenner; Samuel M Behar
Journal:  PLoS Pathog       Date:  2008-12-12       Impact factor: 6.823

10.  CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice.

Authors:  S Cardell; S Tangri; S Chan; M Kronenberg; C Benoist; D Mathis
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

View more
  65 in total

1.  Phospholipid signals of microbial infection for the human immune system.

Authors:  Mitchell Kronenberg; Meng Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-30       Impact factor: 11.205

Review 2.  Lipid antigens in immunity.

Authors:  C Marie Dowds; Sabin-Christin Kornell; Richard S Blumberg; Sebastian Zeissig
Journal:  Biol Chem       Date:  2014-01       Impact factor: 3.915

3.  Self-glycerophospholipids activate murine phospholipid-reactive T cells and inhibit iNKT cell activation by competing with ligands for CD1d loading.

Authors:  Ramesh Chandra Halder; Cynthia Tran; Priti Prasad; Jing Wang; Dhiraj Nallapothula; Tatsuya Ishikawa; Meiying Wang; Dirk M Zajonc; Ram Raj Singh
Journal:  Eur J Immunol       Date:  2018-12-18       Impact factor: 5.532

Review 4.  Optimizing NKT cell ligands as vaccine adjuvants.

Authors:  Leandro J Carreño; Shalu Sharma Kharkwal; Steven A Porcelli
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

5.  Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease.

Authors:  Igor Maricic; Enrico Girardi; Dirk M Zajonc; Vipin Kumar
Journal:  J Immunol       Date:  2014-09-26       Impact factor: 5.422

Review 6.  Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions.

Authors:  Patrick J Brennan; Manfred Brigl; Michael B Brenner
Journal:  Nat Rev Immunol       Date:  2013-01-21       Impact factor: 53.106

Review 7.  Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.

Authors:  Suryasarathi Dasgupta; Vipin Kumar
Journal:  Immunogenetics       Date:  2016-07-12       Impact factor: 2.846

8.  Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation.

Authors:  Shiny Nair; Chandra Sekhar Boddupalli; Rakesh Verma; Jun Liu; Ruhua Yang; Gregory M Pastores; Pramod K Mistry; Madhav V Dhodapkar
Journal:  Blood       Date:  2014-12-11       Impact factor: 22.113

9.  Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response.

Authors:  Jie Zhao; Xiufang Weng; Sreya Bagchi; Chyung-Ru Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

Review 10.  Mechanisms and Consequences of Antigen Presentation by CD1.

Authors:  Luc Van Kaer; Lan Wu; Sebastian Joyce
Journal:  Trends Immunol       Date:  2016-09-09       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.